Reduction in the Number of Astrocytes and Their Projections Is Associated with Increased Synaptic Protein Density in the Hypothalamus of Poorly Controlled Diabetic Rats
Abstract
Processes under hypothalamic control, such as thermogenesis, feeding behavior, and pituitary hormone secretion, are disrupted in poorly controlled diabetes, but the underlying mechanisms are poorly understood. Because glial cells regulate neurosecretory neurons through modulation of synaptic inputs and function, we investigated the changes in hypothalamic glia in rats with streptozotocin-induced diabetes mellitus. Hypothalamic glial fibrillary acidic protein (GFAP) levels decreased significantly 6 wk after diabetes onset. This was coincident with decreased GFAP immunoreactive surface area, astrocyte number, and the extension of GFAP immunoreactive processes/astrocyte in the arcuate nucleus. Cell death, analyzed by terminal deoxyuridine 5-triphosphate nick-end labeling and ELISA, increased significantly at 4 wk of diabetes. Proliferation, measured by Western blot for proliferating cell nuclear antigen and immunostaining for phosphorylated histone H-3, decreased in the hypothalamus of diabetic rats throughout the study, becoming significantly reduced by 8 wk. Both proliferation and death affected astroctyes because both phosphorylated histone H-3- and terminal deoxyuridine 5-triphosphate nick-end labeling-labeled cells were GFAP positive. Western blot analysis revealed that postsynaptic density protein 95 and the presynaptic proteins synapsin I and synaptotagmin increased significantly at 8 wk of diabetes, suggesting increased hypothalamic synaptic density. Thus, in poorly controlled diabetic rats, there is a decrease in the number of hypothalamic astrocytes that is correlated with modifications in synaptic proteins and possibly synaptic inputs. These morphological changes in the arcuate nucleus could be involved in neurosecretory and metabolic changes seen in diabetic animals.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Reactive astroglia increases trophic support, glutamate uptake, isolates lesioned areas favoring regeneration, activates immune pathways, and promotes BBB repair.
“Although reactive astroglia increases trophic support and glutamate uptake, isolates lesioned areas favoring regeneration, activates immune pathways, and promotes BBB repair [38, 43, 45, 46, 47], astrocytes can become dysfunctional and acquire cytotoxic potential under prolonged stress [38, 43].”
From Gliovascular alterations in sporadic and familial Alzheimer's disease: <scp><i>APOE3</i></scp> Christchurch homozygote glioprotection (2023) · cites this paper as [46]
Hypertrophied astrocytes display thicker intermediate filament bundles, highly upregulate GFAP and are associated with neuroprotection and postlesion regeneration.
“hypertrophied astrocytes display thicker intermediate filament bundles, highly upregulate GFAP [45, 109] and are associated with neuroprotection and postlesion regeneration [28, 45, 46, 47].”
From Gliovascular alterations in sporadic and familial Alzheimer's disease: <scp><i>APOE3</i></scp> Christchurch homozygote glioprotection (2023) · cites this paper as [46]
Atrophied astrocytes fail to maintain the glutamate‐glutamine shuttle and display insufficient glutamate clearance because of reduced synaptic coverage, contributing to synaptic extinction and cognitive deficiency.
“previous reports have shown that atrophied astrocytes fail to maintain the glutamate‐glutamine shuttle [28, 47] and display insufficient glutamate clearance [43] because of reduced synaptic coverage [45, 46, 47], contributing to synaptic extinction and cognitive deficiency [43].”
From Gliovascular alterations in sporadic and familial Alzheimer's disease: <scp><i>APOE3</i></scp> Christchurch homozygote glioprotection (2023) · cites this paper as [46]
Atrophied astrocytes are characterized by decreased cell size and reduction of complexity.
“Atrophied astrocytes are characterized by decreased cell size and reduction of complexity [45, 46, 47].”
From Gliovascular alterations in sporadic and familial Alzheimer's disease: <scp><i>APOE3</i></scp> Christchurch homozygote glioprotection (2023) · cites this paper as [46]
The citation lists haven’t been fetched yet
References 81 · Cited by 64
- Authors
- Lechuga-Sancho, A. M., Arroba, A. I., Frago, L. M., García-Cáceres, C., de Célix, A. D.-R., Argente, J., & Chowen, J. A.
- Affiliations
- Hospital Infantil Universitario Niño Jesús (ES)
- Corresponding author
- Chowen, Julie A.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-11-01
- Volume
- 147
- Issue
- 11
- Pages
- 5314-5324
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2065669632
- Cited by
- 64
- References
- 81
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 3 · 2018: 4 · 2017: 1 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 8 · 2012: 7
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Comunidad de Madrid
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- astrocytes, hypothalamus, arcuate nucleus, diabetes mellitus, streptozotocin-induced diabetes, glial fibrillary acidic protein, astrocyte cell death, cell proliferation, synaptic density, PSD-95, synapsin I, synaptotagmin, neurosecretory cells
- MeSH terms
- Animals, Astrocytes, Blood Glucose, Cell Count, Cells, Cultured, Diabetes Mellitus, Experimental, Hypothalamus, Insulin, Male, Nerve Tissue Proteins, Streptozocin, Synapsins, Rats, Wistar, Proliferating Cell Nuclear Antigen, Synaptotagmins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review